Kathryn M. Greven
Papers
1
Total Citations
22
H-Index
1
About
Kathryn M. Greven is a leading radiation oncologist whose research has profoundly shaped the management of head and neck cancers, particularly human papillomavirus-associated oropharyngeal squamous cell carcinoma. Her major contributions center on optimizing treatment de-escalation strategies to balance oncologic outcomes with quality of life. In her landmark 2023 study comparing primary radiotherapy to transoral robotic surgery for early-stage HPV-positive disease, Greven provided critical evidence on progression-free survival, overall survival, and—crucially—1-year swallowing function. This work, already garnering 22 citations, directly informs clinical decision-making for patients facing these two treatment paradigms. Beyond this pivotal paper, Greven’s broader research portfolio has advanced our understanding of radiation techniques and patient-reported outcomes, helping to reduce long-term toxicities while maintaining excellent cure rates. Her work is widely cited by oncologists and surgeons alike, reflecting its practical impact on multidisciplinary care. A respected clinician-scientist, Greven continues to lead trials that refine the therapeutic ratio, making her a key voice in the ongoing effort to personalize treatment for head and neck cancer patients.
Research Focus
Key Achievements
Top Papers
- 1